Tang Capital Management’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Sell |
166,879
-23,760
| -12% | -$137K | 0.05% | 156 |
|
|
2025
Q1 | $1.53M | Hold |
190,639
| – | – | 0.08% | 135 |
|
|
2024
Q4 | $2.04M | Hold |
190,639
| – | – | 0.14% | 106 |
|
|
2024
Q3 | $2.47M | Hold |
190,639
| – | – | 0.18% | 91 |
|
|
2024
Q2 | $2.86M | Buy |
190,639
+19,639
| +11% | +$295K | 0.29% | 70 |
|
|
2024
Q1 | $4.79M | Sell |
171,000
-11,612
| -6% | -$325K | 0.5% | 62 |
|
|
2023
Q4 | $4.09M | Buy |
182,612
+4,760
| +3% | +$107K | 0.38% | 64 |
|
|
2023
Q3 | $3.7M | Buy |
177,852
+11,162
| +7% | +$232K | 0.52% | 51 |
|
|
2023
Q2 | $4.27M | Buy |
166,690
+85,312
| +105% | +$2.18M | 0.63% | 45 |
|
|
2023
Q1 | $2.26M | Buy |
81,378
+61,378
| +307% | +$1.71M | 0.34% | 64 |
|
|
2022
Q4 | $520K | Buy |
20,000
+10,000
| +100% | +$260K | 0.08% | 75 |
|
|
2022
Q3 | $296K | Hold |
10,000
| – | – | 0.04% | 91 |
|
|
2022
Q2 | $408K | Buy |
+10,000
| New | +$408K | 0.06% | 67 |
|